Boehringer Ingelheim to donate 75,000 doses of rabies vaccine to GARC through SHOTS FOR GOOD initiative
In recognition of World Rabies Day on September 28, this significant rabies vaccine donation will support GARC’s efforts to address deaths due to rabies in Madagascar
Merial, now part of Boehringer Ingelheim, announced today it will donate 75,000 doses of rabies vaccine to the Global Alliance for Rabies Control (GARC) in recognition of World Rabies Day on September 28. The donation is the result of SHOTS FOR GOOD, in which Boehringer Ingelheim pledged to donate doses of rabies vaccine for every dose of vaccine purchased by participating veterinary practices from July 2 to August 10, 2018.
“The support of our participating veterinary practices made this donation possible,” said Zach Mills, DVM, executive director of Boehringer Ingelheim’s U.S. Pet Veterinary Professional Services. “BI understands the importance of vaccination to the overall health of pets worldwide. With more than a decade of experience advocating for rabies prevention, the Global Alliance for Rabies Control has the infrastructure to put this donation to good use.”
The donated doses will support a mass dog vaccination campaign in Madagascar. Being an island nation, it provides an area of focus for this donation program, enabling the opportunity to control the disease and limit the potential for reintroduction of rabies from neighboring countries.
“We’re delighted to receive this generous donation from Boehringer Ingelheim made possible by its veterinary customers,” said Professor Louis Nel, chief executive officer of GARC. “Dog-mediated rabies disproportionately affects rural and economically disadvantaged communities. By preventing rabies at its source, we can help protect those who lack access to effective rabies treatment.”
GARC will manage the campaign in Madagascar in concert with the government veterinary services and international and local NGOs. The organizations will use established protocols to plot and record each animal vaccinated along with real-time tracking of the progress of the program to help ensure each priority area is suitably covered before moving on to other areas. The coalition and support from local veterinary services will ensure a sustainable approach embedded in the local community.
“Dog owners in Madagascar want to vaccinate their dogs against rabies, but barriers like cost and access to facilities prevent them from doing so,” Nel added.
Contact us for further information and expert interviews.
View the press release from Boehringer Ingelheim here.